Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Using Period Analysis to Timely Assess and Predict 5-Year Relative Survival for Liver Cancer Patients From Taizhou, Eastern China

Wang, Youqing ; Zhang, Luyao LU ; Han, Fang ; Li, Runhua ; Cheng, Yongran ; Jiang, Xiyi ; Wang, Liangyou ; Chen, Jinfei ; Ji, Jianguang LU orcid and Zhang, Yuhua , et al. (2022) In Frontiers in Oncology 12.
Abstract

Introduction: While timely assessment of long-term survival for patients with liver cancer is essential for the evaluation of early detection and screening programs of liver cancer, those data are extremely scarce in China. We aimed to timely and accurately assess long-term survival for liver cancer patients in eastern China.

Methods: Patients diagnosed with liver cancer during 2004-2018 from four cancer registries with high-quality data from Taizhou, eastern China, were included. The period analysis was used to calculate the 5-year relative survival (RS) for overall and the stratification by sex, age at diagnosis, and region. The projected 5-year RS of liver cancer patients during 2019-2023 was also assessed using a model-based... (More)

Introduction: While timely assessment of long-term survival for patients with liver cancer is essential for the evaluation of early detection and screening programs of liver cancer, those data are extremely scarce in China. We aimed to timely and accurately assess long-term survival for liver cancer patients in eastern China.

Methods: Patients diagnosed with liver cancer during 2004-2018 from four cancer registries with high-quality data from Taizhou, eastern China, were included. The period analysis was used to calculate the 5-year relative survival (RS) for overall and the stratification by sex, age at diagnosis, and region. The projected 5-year RS of liver cancer patients during 2019-2023 was also assessed using a model-based period analysis.

Results: The overall 5-year RS for patients with liver cancer during 2014-2018 reached 32.4%, being 29.3% for men and 36.1% for women. The 5-year RS declined along with aging, decreasing from 38.2% for age <45 years to 18.8% for age >74 years, while the 5-year RS for urban area was higher compared to rural area (36.8% vs. 29.3%). The projected overall 5-year RS of liver cancer patients could reach 41.4% during the upcoming period 2019-2023.

Conclusions: We provided, for first time in China using the period analysis, the most up-to-date 5-year RS for patients with liver cancer from Taizhou, eastern China, and also found that the 5-year RS for liver cancer patients have improved greatly during 2004-2018, which has important implications for the timely evaluation of early detection and screening programs for patients with liver cancer in eastern China.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Frontiers in Oncology
volume
12
article number
920094
publisher
Frontiers Media S. A.
external identifiers
  • scopus:85134534265
  • pmid:35860562
ISSN
2234-943X
DOI
10.3389/fonc.2022.920094
language
English
LU publication?
yes
additional info
Copyright © 2022 Wang, Zhang, Han, Li, Cheng, Jiang, Wang, Chen, Ji, Zhang and Chen.
id
cc25b90a-6f53-42fa-9530-1991f3254330
date added to LUP
2022-07-28 11:46:26
date last changed
2024-04-18 09:36:34
@article{cc25b90a-6f53-42fa-9530-1991f3254330,
  abstract     = {{<p>Introduction: While timely assessment of long-term survival for patients with liver cancer is essential for the evaluation of early detection and screening programs of liver cancer, those data are extremely scarce in China. We aimed to timely and accurately assess long-term survival for liver cancer patients in eastern China.</p><p>Methods: Patients diagnosed with liver cancer during 2004-2018 from four cancer registries with high-quality data from Taizhou, eastern China, were included. The period analysis was used to calculate the 5-year relative survival (RS) for overall and the stratification by sex, age at diagnosis, and region. The projected 5-year RS of liver cancer patients during 2019-2023 was also assessed using a model-based period analysis.</p><p>Results: The overall 5-year RS for patients with liver cancer during 2014-2018 reached 32.4%, being 29.3% for men and 36.1% for women. The 5-year RS declined along with aging, decreasing from 38.2% for age &lt;45 years to 18.8% for age &gt;74 years, while the 5-year RS for urban area was higher compared to rural area (36.8% vs. 29.3%). The projected overall 5-year RS of liver cancer patients could reach 41.4% during the upcoming period 2019-2023.</p><p>Conclusions: We provided, for first time in China using the period analysis, the most up-to-date 5-year RS for patients with liver cancer from Taizhou, eastern China, and also found that the 5-year RS for liver cancer patients have improved greatly during 2004-2018, which has important implications for the timely evaluation of early detection and screening programs for patients with liver cancer in eastern China.</p>}},
  author       = {{Wang, Youqing and Zhang, Luyao and Han, Fang and Li, Runhua and Cheng, Yongran and Jiang, Xiyi and Wang, Liangyou and Chen, Jinfei and Ji, Jianguang and Zhang, Yuhua and Chen, Tianhui}},
  issn         = {{2234-943X}},
  language     = {{eng}},
  publisher    = {{Frontiers Media S. A.}},
  series       = {{Frontiers in Oncology}},
  title        = {{Using Period Analysis to Timely Assess and Predict 5-Year Relative Survival for Liver Cancer Patients From Taizhou, Eastern China}},
  url          = {{http://dx.doi.org/10.3389/fonc.2022.920094}},
  doi          = {{10.3389/fonc.2022.920094}},
  volume       = {{12}},
  year         = {{2022}},
}